| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.2M | +1.3% | — |
| Cost of Revenue | $28.6M | +17.2% | — |
| R&D Expense | $27.9M | +1.7% | -30.8% |
| SG&A Expense | $36.3M | +19.9% | +32.7% |
| Operating Income | -$71.6M | -17.0% | -5.5% |
| Interest Expense | $10.5M | +254.0% | -1.6% |
| Pre-tax Income | -$78.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $86.1M | -30.4% | -86.9% |
| Accounts Receivable | $32.6M | +22.4% | — |
| Inventory | $27.7M | +15.8% | — |
| Current Assets | $514.6M | -10.4% | -28.3% |
| Total Assets | $661.9M | -8.2% | -20.0% |
| Current Liabilities | $83.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$216.2M | — | — |
| Capital Expenditures | $19.9M | — | — |
| Investing Cash Flow | $71.9M | — | — |
| Financing Cash Flow | -$2.5M | — | — |
| Free Cash Flow | -$236.2M | — | — |
| +4.2% |
| Income Tax | $532K | +34.0% | +2318.2% |
| Net Income | -$79.1M | -65.1% | +3.6% |
| EPS (Basic) | -$0.30 | -66.7% | +3.2% |
| EPS (Diluted) | -$0.30 | -66.7% | +3.2% |
| +21.9% |
| +58.3% |
| Total Liabilities | $396.5M | +5.9% | +13.1% |
| Stockholders' Equity | $265.5M | -23.4% | -44.3% |